APACHEⅡ评分对ICU慢性阻塞性肺疾病急性加重期患者预后评价的应用分析  

The analysis of application about APACHE Ⅱ in AECOPD patient

作　　者：王君一[1] 杨晓帆[1] 葛良[1] 高良玉[1] 胡凤杰[1] 何院玲 

机构地区：[1]安徽省安庆市第一人民医院ICU,安徽安庆246002

出　　处：《中国医药导报》2010年第26期31-32,共2页China Medical Herald

摘　　要：目的:探讨APACHEⅡ评分对ICU慢性阻塞性肺疾病急性加重期患者预后判断的应用价值。方法:收集我院100例ICU慢性阻塞性肺疾病急性加重期患者的临床资料,比较各APACHEⅡ分值组患者的死亡率,比较各年龄组死亡患者的APACHEⅡ评分。结果:APACHEⅡ<10分组死亡率为0,10～19分组较≥20分组明显低,≥30分组死亡率为100.00%,各年龄死亡患者组的APACHEⅡ评分无明显差异。结论:APACHEⅡ评分可以用来预测ICU慢性阻塞性肺疾病急性加重期患者的预后。Objective：To investigate the application value of APACHE Ⅱ to the estimation of AECOPD patient healing.Methods：The clinic data of 100 AECOPD patients in the ICU of our hospital were collected.The motalities in different APACHE Ⅱ scores were compared.The APACHE Ⅱ score of different age death patient group were compared.Results：The motality in APACHE Ⅱ score 10 group was 0.The motality APACHEⅡscore 10-19 group was lower than in APACHE Ⅱ score≥20 group.The motality in APACHE Ⅱscore≥30 group was 100.00%.There was an obvious difference among different age death patient groups.Conclusion：The study shows that APACHE Ⅱ score is applicable to estimate the healing of AECOPD patients.

关 键 词：APACHEⅡ评分 慢性阻塞性肺疾病急性加重期 ICU 

分 类 号：R563[医药卫生—呼吸系统]